Literature DB >> 16318624

Myogenic differentiation induces taurine transporter in association with taurine-mediated cytoprotection in skeletal muscles.

Yoriko Uozumi1, Takashi Ito, Yuki Hoshino, Tomomi Mohri, Makiko Maeda, Kyoko Takahashi, Yasushi Fujio, Junichi Azuma.   

Abstract

Skeletal muscle homoeostasis is maintained by a variety of cytoprotective mechanisms. Since ablation of the TauT (taurine transporter) gene results in susceptibility to exercise-induced muscle weakness in vivo, it has been suggested that TauT is essential for skeletal muscle function. However, the regulatory mechanisms of TauT expression remain to be elucidated. In the present study, we demonstrated that TauT was up-regulated during myogenesis in C2C12 cells. Treatment with bFGF (basic fibroblast growth factor), which inhibited muscle differentiation, abrogated myogenic induction of TauT. The promoter activities of TauT were up-regulated during muscle differentiation in C2C12 cells. Database analyses identified an MEF2 (myocyte enhancer binding factor 2) consensus sequence at -844 in the rat TauT gene. Truncation of the promoter region containing the MEF2 site significantly reduced the promoter activity, demonstrating the functional importance of the MEF2 site. Electrophoretic mobility-shift assays confirmed that MEF2 bound to the MEF2 consensus sequence and that DNA-protein complex levels were increased during differentiation. Promoter analyses using mutated promoter-reporter plasmids demonstrated that this site was functional. Importantly, transfection with a MyoD expression vector markedly enhanced TauT promoter activity in the (non-myogenic) 10T1/2 cells. Moreover, co-transfection with an MEF2 expression vector augmented MyoD-induced TauT promoter activity, suggesting that MEF2 is required for full activation of TauT expression. Finally, we examined the effects of taurine on myotube atrophy to clarify the biological significance of the up-regulation of TauT, and demonstrated that taurine attenuated muscle atrophy induced by dexamethasone. TauT expression is regulated under the control of the myogenic programme, and we propose that this is the mechanism for taurine-mediated resistance to muscle atrophy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16318624      PMCID: PMC1383720          DOI: 10.1042/BJ20051303

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  30 in total

1.  Cloning and characterization of the promoter region of the rat taurine transporter (TauT) gene.

Authors:  X Han; A M Budreau; R W Chesney
Journal:  Adv Exp Med Biol       Date:  2000       Impact factor: 2.622

2.  Transcriptional repression of taurine transporter gene (TauT) by p53 in renal cells.

Authors:  Xiaobin Han; Andrea Budreau Patters; Russell W Chesney
Journal:  J Biol Chem       Date:  2002-08-05       Impact factor: 5.157

3.  Regulation of taurine transport at the blood-brain barrier by tumor necrosis factor-alpha, taurine and hypertonicity.

Authors:  Young-Sook Kang; Sumio Ohtsuki; Hitomi Takanaga; Masatoshi Tomi; Ken-Ichi Hosoya; Tetsuya Terasaki
Journal:  J Neurochem       Date:  2002-12       Impact factor: 5.372

4.  Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy.

Authors:  Marco Sandri; Claudia Sandri; Alex Gilbert; Carsten Skurk; Elisa Calabria; Anne Picard; Kenneth Walsh; Stefano Schiaffino; Stewart H Lecker; Alfred L Goldberg
Journal:  Cell       Date:  2004-04-30       Impact factor: 41.582

5.  Taurine transporter knockout depletes muscle taurine levels and results in severe skeletal muscle impairment but leaves cardiac function uncompromised.

Authors:  Ulrich Warskulat; Ulrich Flögel; Christoph Jacoby; Hans-Georg Hartwig; Michael Thewissen; Marc W Merx; Andrej Molojavyi; Birgit Heller-Stilb; Jürgen Schrader; Dieter Häussinger
Journal:  FASEB J       Date:  2004-01-20       Impact factor: 5.191

6.  Enhanced dystrophic progression in mdx mice by exercise and beneficial effects of taurine and insulin-like growth factor-1.

Authors:  Annamaria De Luca; Sabata Pierno; Antonella Liantonio; Michela Cetrone; Claudia Camerino; Bodvael Fraysse; Massimo Mirabella; Serenella Servidei; Urs T Rüegg; Diana Conte Camerino
Journal:  J Pharmacol Exp Ther       Date:  2003-01       Impact factor: 4.030

7.  Effects of taurine administration in rat skeletal muscles on exercise.

Authors:  Yoshihisa Yatabe; Shumpei Miyakawa; Teruo Miyazaki; Yasushi Matsuzaki; Naoyuki Ochiai
Journal:  J Orthop Sci       Date:  2003       Impact factor: 1.601

Review 8.  Regulation of the cellular content of the organic osmolyte taurine in mammalian cells.

Authors:  Ian Henry Lambert
Journal:  Neurochem Res       Date:  2004-01       Impact factor: 3.996

9.  The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors.

Authors:  Trevor N Stitt; Doreen Drujan; Brian A Clarke; Frank Panaro; Yekatarina Timofeyva; William O Kline; Michael Gonzalez; George D Yancopoulos; David J Glass
Journal:  Mol Cell       Date:  2004-05-07       Impact factor: 17.970

10.  Tumor necrosis factor alpha stimulates taurine uptake and transporter gene expression in human intestinal Caco-2 cells.

Authors:  Tetsunosuke Mochizuki; Hideo Satsu; Makoto Shimizu
Journal:  FEBS Lett       Date:  2002-04-24       Impact factor: 4.124

View more
  13 in total

1.  Effect of beta-alanine treatment on mitochondrial taurine level and 5-taurinomethyluridine content.

Authors:  Chian Ju Jong; Takashi Ito; Mahmood Mozaffari; Junichi Azuma; Stephen Schaffer
Journal:  J Biomed Sci       Date:  2010-08-24       Impact factor: 8.410

2.  A maternal low protein diet has pronounced effects on mitochondrial gene expression in offspring liver and skeletal muscle; protective effect of taurine.

Authors:  Ole Hartvig Mortensen; Hanne Lodberg Olsen; Lis Frandsen; Peter Eigil Nielsen; Finn Cilius Nielsen; Niels Grunnet; Bjørn Quistorff
Journal:  J Biomed Sci       Date:  2010-08-24       Impact factor: 8.410

3.  Hyperreflexia and enhanced ripple oscillations in the taurine-deficient mice.

Authors:  Narmin Mekawy; Meriem Bendaoud; Yassine Yachou; Abdeslem El Idrissi
Journal:  Amino Acids       Date:  2021-04-20       Impact factor: 3.520

Review 4.  Taurine: the appeal of a safe amino acid for skeletal muscle disorders.

Authors:  Annamaria De Luca; Sabata Pierno; Diana Conte Camerino
Journal:  J Transl Med       Date:  2015-07-25       Impact factor: 5.531

5.  Tissue taurine depletion alters metabolic response to exercise and reduces running capacity in mice.

Authors:  Takashi Ito; Natsumi Yoshikawa; Stephen W Schaffer; Junichi Azuma
Journal:  J Amino Acids       Date:  2014-11-12

Review 6.  Dietary thiols in exercise: oxidative stress defence, exercise performance, and adaptation.

Authors:  Yanita McLeay; Stephen Stannard; Stuart Houltham; Carlene Starck
Journal:  J Int Soc Sports Nutr       Date:  2017-04-27       Impact factor: 5.150

7.  In Vivo and In Vitro Study of N-Methyltaurine on Pharmacokinetics and Antimuscle Atrophic Effects in Mice.

Authors:  Khanh Hoang Nguyen; Shunta Ito; Sayuri Maeyama; Stephen W Schaffer; Shigeru Murakami; Takashi Ito
Journal:  ACS Omega       Date:  2020-05-08

8.  Protective role of taurine against oxidative stress (Review).

Authors:  Stella Baliou; Maria Adamaki; Petros Ioannou; Aglaia Pappa; Mihalis I Panayiotidis; Demetrios A Spandidos; Ioannis Christodoulou; Anthony M Kyriakopoulos; Vassilis Zoumpourlis
Journal:  Mol Med Rep       Date:  2021-06-29       Impact factor: 2.952

9.  Cited3 activates Mef2c to control muscle cell differentiation and survival.

Authors:  Gnanapackiam Sheela Devakanmalai; Hasan E Zumrut; Ertuğrul M Ozbudak
Journal:  Biol Open       Date:  2013-04-11       Impact factor: 2.422

Review 10.  Taurine Reverses Oxidative Damages and Restores the Muscle Function in Overuse of Exercised Muscle.

Authors:  Anand Thirupathi; Ricardo A Pinho; Julien S Baker; Bíró István; Yaodong Gu
Journal:  Front Physiol       Date:  2020-10-26       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.